ArticleCancer gene therapy2013

Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer.

L Zou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.